𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hypoxia inducible BHLHB2 is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma

✍ Scribed by Weibin Wang; Carolin Reiser-Erkan; Christoph W. Michalski; Matthias C. Raggi; Liao Quan; Zhao Yupei; Helmut Friess; Mert Erkan; Jörg Kleeff

Book ID
116300865
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
1014 KB
Volume
401
Category
Article
ISSN
0006-291X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High expression of tumor-associated anti
High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker
✍ Kei Hiraoka; Yasuhiro Hida; Masaki Miyamoto; Taro Oshikiri; Masato Suzuoki; Yosh 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 381 KB

## Abstract RCAS1 (receptor‐binding cancer antigen expressed on SiSo cells) is a recently identified human tumor‐associated antigen expressed on various cancer cells. It is thought that tumor cells evade immune surveillance by expression of RCAS1, which induces apoptotic cell death in receptor‐posi

L1 Cell adhesion molecule (L1CAM) expres
L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma
✍ Shinji Tsutsumi; Satoko Morohashi; Yasuyuki Kudo; Harue Akasaka; Hiroshi Ogasawa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

## Abstract ## Background and Objectives Pancreatic ductal adenocarcinoma (PDAC) is one of the most extremely aggressive cancers with a poor prognosis after curative resection. L1 cell adhesion molecule (L1CAM) is a 200–220 kDa type I transmembrane glycoprotein of the immunoglobulin superfamily, w